Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara A Goff

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Journal of General Internal Medicine|August 15, 2013
Guideline-inconsistent breast cancer screening for women over 50: a vignette-based surveyHajar Kadivar, Barbara A Goff, William R Phillips, et al.
American Journal of Obstetrics and Gynecology|September 20, 2020
ReplyRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Human Pathology|January 30, 2007
Alternate molecular genetic pathways in ovarian carcinomas of common histological typesJulia Willner, Kaitlyn Wurz, Kimberly H Allison, et al.
Molecular Cancer|July 16, 2009
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomasElizabeth M Swisher, Rachel M Gonzalez, Toshiyasu Taniguchi, et al.
Gynecologic Oncology|December 13, 2005
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium, Elizabeth M Swisher, Ron E Swensen, et al.
Gynecologic Oncology Reports|April 25, 2025
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaireEric D Helm, Cam Nguyen, Stephen Rotholz, et al.
Gynecologic Oncology|April 19, 2011
Trends in treatment of advanced epithelial ovarian cancer in the Medicare populationMelissa M Thrall, Heidi J Gray, Rebecca Gaston Symons, et al.
Translational Oncology|September 1, 2012
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinomaTilley Jenkins Vogel, Christiana Dellorusso, Piri Welcsh, et al.
Genes, Chromosomes & Cancer|May 13, 2010
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survivalKaitlyn Wurz, Rochelle L Garcia, Barbara A Goff, et al.
Gynecologic Oncology Reports|January 21, 2026
Treatment delay and prolongation in locally advanced cervical cancerMaya Gross, Joyce Y Wang, Barbara A Goff, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Journal of General Internal Medicine|August 15, 2013
Guideline-inconsistent breast cancer screening for women over 50: a vignette-based surveyHajar Kadivar, Barbara A Goff, William R Phillips, et al.
American Journal of Obstetrics and Gynecology|September 20, 2020
ReplyRonald D Alvarez, Barbara A Goff, David Chelmow, et al.
Human Pathology|January 30, 2007
Alternate molecular genetic pathways in ovarian carcinomas of common histological typesJulia Willner, Kaitlyn Wurz, Kimberly H Allison, et al.
Molecular Cancer|July 16, 2009
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomasElizabeth M Swisher, Rachel M Gonzalez, Toshiyasu Taniguchi, et al.
Gynecologic Oncology|December 13, 2005
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium, Elizabeth M Swisher, Ron E Swensen, et al.
Gynecologic Oncology Reports|April 25, 2025
Feasibility of assessing symptoms associated with ovarian cancer using an electronic medical intake questionnaireEric D Helm, Cam Nguyen, Stephen Rotholz, et al.
Gynecologic Oncology|April 19, 2011
Trends in treatment of advanced epithelial ovarian cancer in the Medicare populationMelissa M Thrall, Heidi J Gray, Rebecca Gaston Symons, et al.
Translational Oncology|September 1, 2012
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinomaTilley Jenkins Vogel, Christiana Dellorusso, Piri Welcsh, et al.
Genes, Chromosomes & Cancer|May 13, 2010
MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survivalKaitlyn Wurz, Rochelle L Garcia, Barbara A Goff, et al.
Gynecologic Oncology Reports|January 21, 2026
Treatment delay and prolongation in locally advanced cervical cancerMaya Gross, Joyce Y Wang, Barbara A Goff, et al.
Pageof 13